- Targeted stakeholdersMay improve the technical quality of CBO health analyses and cost estimates.
- Targeted stakeholdersIncreases public transparency by requiring an annual published report and CBO response.
- Targeted stakeholdersBrings external expertise in health finance, actuarial science, and delivery systems into analyses.
HEALTH Panel Act
Read twice and referred to the Committee on the Budget.
This bill amends the Congressional Budget and Impoundment Control Act to create a 15-member Panel of Health Advisors within the Congressional Budget Office.
The Panel will provide technical expertise on CBO health studies, cost estimates, models, and publications; meet at least annually; issue an annual report with recommendations; and have members appointed by budget committee chairs/ranking members and the CBO Director.
The Director must publish the annual report, may set disclosure/confidentiality rules, and members serve staggered three-year terms as special government employees, limited to two terms.
Narrow, administrative, and bipartisan mechanics improve prospects, but many technical bills nonetheless stall in committee or face concern over conflicts and resource needs.
Relative to its intended legislative type, this bill provides a clear statutory framework for a CBO-based advisory panel on health, with specific membership rules, defined duties, and an annual reporting and publication requirement. It codifies many expected elements of an advisory body while leaving several operational and resourcing matters unspecified.
Progressives stress transparency and conflict-of-interest safeguards.
Who stands to gain, and who may push back.
- Targeted stakeholdersCreates a risk of conflicts of interest if industry-affiliated experts serve on the Panel.
- Targeted stakeholdersConfidentiality agreements could limit public access to information underlying CBO analyses.
- Targeted stakeholdersAdds administrative costs and staff time for CBO to manage appointments and reports.
Why the argument around this bill splits.
Progressives stress transparency and conflict-of-interest safeguards.
Generally supportive of improving CBO technical capacity on health policy, but cautious about appointments and conflicts of interest.
Will welcome clearer, more rigorous cost estimates for health legislation while demanding strong transparency and public-interest representation.
Favorable overall: codifying expert advice to CBO is pragmatic and likely to improve legislative scoring.
Wants clear conflict-of-interest safeguards, predictable processes, and minimal politicization before full endorsement.
Cautious-to-moderately supportive if the Panel improves CBO accuracy without expanding federal bureaucracy.
Prefers members with private-sector experience and protections for proprietary data; skeptical of new federal boards generally.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow, administrative, and bipartisan mechanics improve prospects, but many technical bills nonetheless stall in committee or face concern over conflicts and resource needs.
- No Congressional Budget Office cost estimate included
- Potential concerns about appointee conflicts of interest
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Progressives stress transparency and conflict-of-interest safeguards.
Narrow, administrative, and bipartisan mechanics improve prospects, but many technical bills nonetheless stall in committee or face concern…
Relative to its intended legislative type, this bill provides a clear statutory framework for a CBO-based advisory panel on health, with specific membership rules, defined duties, and an annual reporting and publication…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.